Global Statistics

All countries
176,951,869
Confirmed
Updated on June 14, 2021 4:47 pm
All countries
159,338,147
Recovered
Updated on June 14, 2021 4:47 pm
All countries
3,823,522
Deaths
Updated on June 14, 2021 4:47 pm
Monday, June 14, 2021

Global Statistics

All countries
176,951,869
Confirmed
Updated on June 14, 2021 4:47 pm
All countries
159,338,147
Recovered
Updated on June 14, 2021 4:47 pm
All countries
3,823,522
Deaths
Updated on June 14, 2021 4:47 pm
Molderizer and Safe Shield

OHSU coronavirus (COVID-19) response | OHSU News

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...

As US COVID-19 Death Toll Nears 600,000, Racial Gaps Persist | Chicago News

In this April 22, 2020, file photo, pallbearers, who were among only 10 allowed mourners, walk the casket for internment at the funeral...

Communication technology, study of collective behavior must be ‘crisis discipline,’ researchers argue

News releases June 14, 2021 Our ability to confront global crises,...


close up of a pair of Caucasian hands injecting a vaccine into an adult's upper arm

As of Thursday, June 10



OHSU community vaccinations


  • OHSU has administered 343,131 vaccine doses through its community vaccination sites, in addition to the 540,275 vaccine doses administered to date through the Oregon Convention Center vaccination site, which is jointly managed by OHSU, Legacy Health, Kaiser Permanente and Providence Health & Services. (For more information about community locations and who is eligible, see “Community COVID-19 vaccination sites” below.)


OHSU staff vaccinations


  • As of June 10, OHSU has fully vaccinated 16,863 employees and students, plus an additional 212 who are partially vaccinated. A total of 5,575 employees and students have not yet been vaccinated. 


Patients hospitalized with COVID-19


  • OHSU: 5
  • Hillsboro Medical Center: 3
  • Adventist Health Portland: 7


Additional OHSU-specific data


  • Since Feb. 28, 2020, there have been 145,656 patients tested. Among those, a total of 13,020 COVID-19 cases have been detected; 5 patients are currently in hospital; and, 186 patients have tests pending. There have been 66 in-hospital deaths.
  • There have been 12 new detected patient cases since June 9.
  • To date, OHSU has completed 25,891 COVID-19 tests for 8,615 staff and students. Of those, 550 tests for 532 staff and students detected COVID-19; 25,246 tests for 8,335 individuals resulted in not detected; 95 tests are pending.

As the state’s academic health center, Oregon Health & Science University remains engaged with state and local public health authorities and health systems across the metro area to coordinate a regional response to the COVID-19 pandemic. The goal is to contain the spread of the virus, including through the use of vaccines that first arrived at OHSU on Dec. 15.

Beginning in the earliest days of the pandemic, OHSU activated an emergency operations center that adapted response plans already in place from previous pandemic influenza outbreaks.

OHSU has prepared to treat a surge of patients with COVID-19, while working proactively to contain the spread of the SARS-CoV-2 virus and protect our workforce.


Community COVID-19 vaccination sites

OHSU has committed its entire organization to deploying COVID-19 vaccines as soon as they are available, starting with difficult-to-reach community members and underserved communities.

OHSU has established an online resource to help OHSU patients make an appointment to get vaccinated. The university has also engaged students and trainees to vaccinate Oregonians.

At this time, OHSU Health is collaborating with community partners and other hospitals and health systems to offer vaccinations at the following mass vaccination sites:

  • Portland International Airport, Red Economy Parking Lot 

    • Drive-through clinic available with or without an appointment. Dates remaining include June 12-13 and June 19.
    • Collaborating organizations: OHSU, American Red Cross, Port of Portland

  • Oregon Convention Center 

    • Indoor clinic, which will remain open through June 19. Specific hours and details.
    • Collaborating organizations: Kaiser Permanente, OHSU, Providence, Legacy Health

  • OHSU Multnomah Pavilion, Marquam Hill Campus 

    • Indoor clinic will remain available by appointment for OHSU patients.
    • Note that vaccinations will also remain available at OHSU’s Richmond clinic in southeast Portland and its Scappoose clinic.

  • Hillsboro Stadium, 4450 N.E. Century Blvd., Hillsboro

    • Drive-through, walk up or arrive by bike or transit. As of today, this mass vaccination site will be open June 10-11, June 17-18, and June 21-25.
    • Collaborating organizations: OHSU, Hillsboro Medical Center


Mobile, drive-through testing


As Oregon’s academic health center, OHSU is committed to ensuring all Oregonians have access to COVID-19 testing and appropriate health care, particularly people of color and other individuals from communities hardest hit by COVID-19. Throughout the course of the pandemic, OHSU has offered low-barrier drive-through testing that has tracked surges in case counts, at various points accommodating as many as 700 people a day through sites in Hillsboro, the Oregon Convention Center and the Portland Expo Center.

OHSU continues to operate a low-barrier drive-up testing facilityat the Portland Expo Center. This low-barrier testing site does not require an appointment or referral, is free to the patient (although insurance will be charged if the patient has insurance) and is available to OHSU and non-OHSU patients alike:

  • Portland Expo Center – 2060 N. Marine Drive 

    • Hours (note that wait times may vary depending on demand, and site may close early):

      • Monday – Thursday: 9 a.m. – 4 p.m. 
      • Friday: 7:30 a.m. – 2:30 p.m. 

Learn more about details of testing. Guidelines may change at any time based on updated recommendations.


Patient care

  • Patient visitation: Support of friends and family is an important part of healing. Details of OHSU’s current patient visitation policy can be found here. 
  • OHSU has established a Long COVID-19 Program to provide comprehensive, coordinated care for people experiencing debilitating symptoms months after their infection.
  • OHSU has established a series of steps to prepare patients who have recovered from COVID-19 for elective surgery following their illness. It’s believed to be the first published protocol laying out a COVID-era path forward in American medicine.
  • OHSU has implemented a “mask on” policy for all patients, visitors and staff inside the hospital. For employees, this means anyone working in a patient-care area, in hallways, and in research labs. All employees who work in patient care areas will receive masks provided by OHSU. OHSU is asking all employees to conserve supplies as much as safely possible to preserve these precious resources for the entire institution and their colleagues.
  • OHSU’s research community came together to launch an in-house COVID-19 testing lab on March 24, 2020. The lab is an example of the many collaborations that have been happening at OHSU and in the health care community. In this case, members of the research community rallied to support the clinical community and testing in a drive to combat COVID-19. The lab’s capacity greatly expanded in October 2020.
  • OHSU’s Telemedicine Program offers an opportunity for patients to consult with licensed clinicians through a telephone or video connection from their home, limiting barriers to health care access. The service has expanded exponentially in response to COVID-19.

Workforce management

  • OHSU has offered childcare accommodations, including a $7.5 million hardship stipend, to help sustain its workforce during the pandemic.
  • A training video OHSU developed to prepare its students and staff to give COVID-19 vaccines is now being used to train California paramedics and emergency medical technicians as that state ramps up its fight against the pandemic.
  • OHSU suspended work-related travel beginning the week of March 9, 2020, with exceptions primarily related to clinicians providing patient care to sites around the Portland metro area and Oregon. The goal is to minimize quarantines of health care workers and help to slow the spread of the virus.
  • OHSU has instituted a wellness program designed to support clinicians, employees and students during the COVID-19 pandemic. One example is a grant-funded program that paid local restaurants to supply hot meals for high-impact frontline health care workers following the holidays.
  • OHSU is promoting physical distancing within the university, including by requiring non-critical function employees to work remotely and minimizing the number of people gathered for in-person meetings through video and teleconferencing alternatives. 

Research and development

  • OHSU research published online on April 29 suggets that people previously infected with the novel coronavirus stand to get a much better benefit of protection against new variants if they’re vaccinated. An earlier laboratory study highlighted the importance of stopping the spread of virus variants through vaccination. 
  • An OHSU study aims to better understand the immune system’s response to COVID-19 during and after pregnancy.
  • On Nov. 30, OHSU announced it is part of a Phase 3 clinical trial for a vaccine candidate developed by Oxford University and the pharmaceutical company AstraZeneca.
  • OHSU scientists and physicians are engaged in a multipronged effort across the institution to improve scientific understanding of the novel coronavirus and bring the pandemic under control.
  • OHSU is partnering with the local nonprofit Self Enhancement Inc. on a pilot study that combines wastewater monitoring with voluntary saliva-based testing of residents in four Portland neighborhoods. Preliminary results are promising, and the project has helped forge connections with historically underserved communities.
  • An OHSU-led evidence review, published in June 2020, finds that facial coverings appear to decrease the risk of spreading respiratory illnesses in community settings.
  • OHSU data scientist Peter Graven, Ph.D., modeled the projected unchecked spread of the virus and began sharing those projections with state and local policymakers at the onset of the pandemic in Oregon in March of 2020. These projections helped inform Oregon’s “Stay Home, Save Lives” efforts to reduce the spread of the virus and ensure it doesn’t exceed the capacity of health systems to treat a surge of patients who required hospitalization.
  • OHSU data scientists are leading a nationwide collaboration of clinicians, informaticians and other biomedical researchers aims to turn data from hundreds of thousands of medical records from coronavirus patients into effective treatments and predictive analytical tools that could help lessen or end the global pandemic.
  • OHSU has joined with other universities and academic medical centers across the country to ease licensing requirements to expedite promising new technologies to diagnose, treat and prevent COVID-19. 

Community measures

  • In the war against COVID-19, OHSU is racing to vaccinate as many Oregonians as quickly as possible. Over time, the goal is to drive the virus into submission by cutting off its ability to spread.
  • OHSU is deploying three mobile testing vans to increase the availability of testing in Oregon communities lacking easy access. The vans can be easily adapted to transition to vaccinating Oregonians as vaccine availability ramps up in the weeks and months ahead.
  • On Dec. 3, Gov. Kate Brown appointed Louis Picker, M.D., as one of two Oregon scientists to independently review the safety and efficacy of COVID-19 vaccines that receive emergency use authorization from the U.S. Food and Drug Administration. On Dec. 11, Brown appointed OHSU Chief Administrative Officer Connie Seeley as special advisor for vaccine implementation in Oregon.
  • OHSU established a Connected Care Center, available by phone to people throughout Oregon seeking insight about care of symptoms related to COVID-19. The phone number is 833-647-8222.
  • OHSU President Danny Jacobs, M.D., M.P.H., FACS, joined other national health care leaders in raising alarm about disparities in health outcomes along racial and socioeconomic lines among those stricken by COVID-19. OHSU researchers confirmed the disproportionate impact of the virus on Black and Hispanic populations with an evidence review published Dec. 1.

Ways to help

Please consult these resources for the most current information on the COVID-19 response:





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...

Related Articles

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...